Hedgeye Quality Growth ETF (NYSEARCA:HGRO) Short Interest Down 83.8% in August
by Doug Wharley · The Cerbat GemHedgeye Quality Growth ETF (NYSEARCA:HGRO – Get Free Report) saw a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 7,582 shares, a drop of 83.8% from the August 15th total of 46,748 shares. Based on an average daily trading volume, of 34,064 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.2% of the company’s stock are short sold.
Hedgeye Quality Growth ETF Price Performance
Shares of HGRO traded up $0.08 during trading hours on Friday, reaching $29.68. 35,731 shares of the company traded hands, compared to its average volume of 62,717. The business has a fifty day moving average price of $30.55 and a 200-day moving average price of $30.05. Hedgeye Quality Growth ETF has a 12-month low of $26.86 and a 12-month high of $31.85.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Hedgeye Quality Growth ETF stock. Copia Wealth Management bought a new stake in shares of Hedgeye Quality Growth ETF (NYSEARCA:HGRO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 5,311 shares of the company’s stock, valued at approximately $151,000. Copia Wealth Management owned approximately 0.20% of Hedgeye Quality Growth ETF at the end of the most recent reporting period.
About Hedgeye Quality Growth ETF
HGRO is an actively managed, large-cap U.S. equity ETF with approximately 40–50 high-conviction holdings. It focuses on three categories—Deep Moat Compounders, Innovators/Disruptors & S-Curve Beneficiaries, and Idiosyncratic Special Situations—to pursue long‑term capital appreciation. The fund is managed by veteran portfolio manager Sam Rahman, who brings over 30 years of investment experience.
See Also
- Five stocks we like better than Hedgeye Quality Growth ETF
- Why Bitcoin ETFs May Be Worth Another Look as Inflows Rebound
- 3 Small-Cap Biotechs With Binary Catalysts on the Calendar
- Planet Labs Has Fallen Back to Earth, But Wall Street Still Sees a Rebound
- As Homeowners’ Premiums Surge, This Insurer Is Posting Record Profits